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OBJECTIVES: In economic theory economic surplus refers to two related quantities:
Consumer surplus (monetary gain obtained by consumers because they are able to
purchase a product for a price that is less than the highest price they would be
willing to pay) and producer surplus (amount that producers benefit by selling at a
market price that is higher than the least they would be willing to sell for). Applying
the theory to health care economic surplus could be translated as convenience
benefits which could be skimmed by patients, physicians or health care payers.
METHODS:Various areas of economic surplus were being screened and three areas
in Germany, the Netherlands and the UK were analysed: Caesarean births, emer-
gency room visits (nights or weekends) and response surplus. A targeted literature
search was being conducted to identify the costs. The economic surplus (conve-
nience value) was calculated. RESULTS: The economic surplus for non-medical
driven Caesarean births was calculated as the difference of a DRG (Diagnosis Re-
lated Groups) for a vaginal birth and a Caesarean birth in Germany and was equal
to € 828 per case. In the UK emergency visits during nights or weekends were
analysed. Standard HRG (Healthcare Resource Group) value for an emergency visit
was applied and the theoretical surplus was calculated applying a proxy-add-on
taken from the proportionally higher wages during premium times and was rang-
ing between € 94 and € 137 per case for nights shifts and weekends respectively. As
an example of response surplus IVF-treatments in the Netherlands were chosen
where it can be shown that there might be a patient surplus of up to € 4’096 per
saved IVF-treatment. CONCLUSIONS: The application of standard economic the-
ory confirms the availability of surplus skimming in health care and shows that
health care systems are indirectly accepting and paying for convenience.
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Schlander M, Schwarz O
Institute for Innovation & Valuation in Health Care, Wiesbaden, Germany
OBJECTIVES: The Nordbaden Project was established in 2003 as a cross-sectional
analysis of the administrative prevalence, resource use, and direct medical costs
associated with attention-deficit/hyperactivity disorder (ADHD). Meanwhile, the
project has evolved into a longitudinal patient-centered study, allowing to follow
identified patients over prolonged periods of time and to study the impact of mod-
erators (e.g., coexisting conditions) and mediators (e.g., specialist involvement) on
the quality and cost of health care services provided. The database enables retro-
spective health care utilization studies based upon claims data of the Kassenaerztli-
che Vereinigung (KV) in Nordbaden (“Regierungsbezirk Karlsruhe”), an affluent region
in Southwestern Germany. METHODS: The database covers the complete regional
population enrolled in statutory health insurance (SHI; 2.2 million lives). Based
upon prospective data analysis plans, the vdek group of sick funds within SHI
(850,000 lives in year 2009) offers prescription data for the subsample of patients
insured by its member companies. Here, sociodemographic data of the study sam-
ple are compared to national averages (year 2009) to assess its representativeness.
RESULTS: The demographic structure (by age and gender) of the Nordbaden sam-
ple (including its vdek subgroup) compares well to the national population. How-
ever, regional population density is much higher (396/sqkm versus 229/sqkm in
2009), and GDP per capita (34,800€ versus 29,300€) as well as the rate of persons
insured by private sick funds (instead of SHI: 18.2% versus 14.6%) exceed the na-
tional average. There are also relatively more health care specialists in Nordbaden
(for example, 11,400 persons per mental health care specialist and 3,200 per psy-
chotherapist) compared to Germany (17,200 and 3,900, respectively), whereas the
relative number of general practitioners is somewhat lower (with 1,500 persons per
g.p. versus 1,400). CONCLUSIONS: The Nordbaden sample constitutes a well-char-
acterized study population. However, interpretation of observations should take
into account the well-documented differences between region and nation.
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OBJECTIVES: To analyses the policies implemented for the pricing, promotion and
classification of over-the-counter (OTC) drugs, in several European countries and to
compare them with those in Greece. METHODS: The study presents in detail the
structure of the prescription drug (Rx) and OTC market and the prevailing corre-
sponding policies in 23 European countries. The data used in the study were mainly
derived from the published literature and were synthesized and categorized with
emphasis on the classification process, pricing, reimbursement and promotion of
Rx and OTC. The above process was used to reveal and highlight commonalities
and differences between the countries. RESULTS: It was found that the great ma-
jority of European countries apply free pricing for OTC drugs and only few countries
choose state intervention. The 21 out of the 23 countries allow the OTC market to
self regulate through the mechanisms of the market and competition and the main
exclusion is Greece, which is one of the two countries, from those examined, which
the government regulates the prices of OTC drugs. This policy initially was in-
tended to protect consumers from excessive pricing and overconsumption of
widely used drugs but has opposite results. In terms of the content, the analysis
indicates that the positive and negative lists are wider in the case of Greece and the
OTC list is narrower compared with the remaining countries. CONCLUSIONS: In-
ternational experience indicates that the OTC list in Greece is narrower and heavily
regulated in terms of price relative to other countries. This may lead to opposite
results that those intended by budget holders. Careful expansion of the OTC list
along with release of their prices, may lead to savings for the public spending and
greater access to patients at reasonable cost and a patient level.
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OBJECTIVES: To estimate the economic impact of switching established prescrip-
tion drugs (Rx) to over-the-counter drugs (OTC), for different stakeholders (pa-
tients, social insurance funds, the national economy, physicians). METHODS: An
algorithm was constructed to estimate the percentage of drugs that could be trans-
ferred from the positive and the negative list to the OTC one, based on data ob-
tained from the OTC lists of 24 countries in Europe. In the algorithm, it was as-
sumed that a drug could be transferred in the OTC list in Greece if it was included
in the corresponding list of at least seven other European countries. Based on this
approach, it was calculated that 4.3% and 40% of drugs belong to the reimburse-
ment and negative list, respectfully, could be shifted to the OTC list. The economic
impact of the switch was estimated based on the reduction of medical visits, the
change of drug prices, the chance of copayments, the reduction in transportation
costs and the increase of patient productivity. The analysis was stochastic.
RESULTS: In the base case scenario, the total annual savings for the social funds is
estimated at 170€ million and the benefit for the economy at 78,96€ million. Pa-
tients are charged with extra 95€ million for drugs. It is estimated that the switch
reduces the number of medical visits by 1,8 million and saves 1,28 million days of
work. An increase of individual per capital expenditure by 9.4€ due to switch to OTC
drugs could benefit by 249€ million to the national economy. These results were
confirmed in two additional scenarios. CONCLUSIONS: The findings of this study
suggest that the Rx-to-OTC switch may reduce the health care costs of social se-
curity funds and may benefit the national economy overall, with some reasonable
extra costs incurred by patients on an individual basis.
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OBJECTIVES: Greece goes through a major economic crisis and a reform program,
in the context of which an aim is to cut by half drug spending within four years.
Expansion of the over-the-counter (OTC) drug list could contribute to the reduction
of public spending. Hence, a review was undertaken to investigate the implications
of expanding their use. METHODS: Relevant published studies examining the ef-
fect of using OTC drugs were identified with search in MEDLINE, EBSCO and
PUBMED. The literature search was based on the following terms: Over the counter,
OTC, drugs, prescription medicine, Rx, Non Rx, benefit, economic impact, self-care.
Studies were included based on the following criteria: peer-reviewed English-lan-
guage articles, published from 2000 and over, cited at least in 25 other articles. The
selected studies were divided into three groups based on the stakeholder for whom
the study had been conducted. RESULTS: For patients, the shift of drugs from
prescription to OTC status leads to increased access, greater utilization, reduced
traveling cost and physician payments, increases in productivity and drug expen-
diture. The switch reduces public spending on drugs and physician visits. However,
the expansion of the OTC list may in certain cases be associated with risks and
negative effects on health outcomes, if patients are not well informed regarding the
ways of responsible self-medication. Finally, the literature review revealed that
patients are more likely to prefer a, more expensive, prescription drug from a
cheaper but similar in effectiveness non-prescription one if both are available.
CONCLUSIONS: It is evident that the greater use of OTC drugs may improve access,
convenience, service, health outcomes and patient satisfaction and may reduce
the expenditures of social insurance, under certain well controlled and designed
circumstances. In particular the drugs need to be carefully selected and the pa-
tients and pharmacists well informed and trained on responsible self-medication.
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OBJECTIVES: Aging population, chronic conditions and financial constraints are
among the main challenges for our health care organization. Disease management
programs and multidisciplinary teams are often proposed as possible solutions
but, while cost effectiveness (CE) is well accepted and almost evident in the eval-
uation of drugs and technologies, it is not sure that it is also common use in the
implementation of new health care programs. METHODS: In December 2011 we
conducted a search for publications since 2000, in Pubmed, Cinahl, Econlit and
Biomed Central, with “care program” or “disease management program” or “reha-
bilitation program” as mesh terms. To identify in how many cases generic health-
related quality of life (HR-QoL) questionnaires were used, the search was extended
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